Placebo: Its Action and Place in Health Research Today - Summary and Conclusions

Science and Engineering Ethics

Volumn 10, Issue 1, 2004, Pages 189-197

  Spier, Raymond E ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Dose response; Ethics; Nocebo; Placebo

Indexed keywords

ANTIBIOTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC RHINITIS; ARTHRITIS; ASTHMA; ATTENTION DEFICIT DISORDER; BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DEVELOPING COUNTRY; DIABETES MELLITUS; DRUG EFFICACY; ECZEMA; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEART INFARCTION; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS; HOMEOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFECTION; INFORMED CONSENT; INTESTINE INFECTION; LUNG TUBERCULOSIS; MALARIA; MEDICAL ETHICS; MEDICAL RESEARCH; MIGRAINE; NONHUMAN; PAPILLOMA VIRUS; PARKINSON DISEASE; PSORIASIS; PSYCHOSOMATIC DISORDER; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; SCHIZOPHRENIA; STOMACH ULCER;

EID: 1242306789     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-004-0076-7     Document Type: Conference Paper

References (18)

1. Smoak, Jr., R. (2004) Placebo: Its Action and Place in Health Research Today, Science and Engineering Ethics 10: 9-13.
2. Idänpään-Heikkilä, J.E. and Sev Fluss, S. (2004) The CIOMS View on the Use of Placebo in Clinical Trials, Science and Engineering Ethics 10: 23-28.
3. Zilgalvis, P. (2004) Placebo use in Council of Europe biomedical research instruments, Science and Engineering Ethics 10: 15-22.
4. Gerold, R. (2004) Ethics in research: Striving for common ground within the cultural diversity of Europe, Science and Engineering Ethics 10: 5-8.
5. Szawarski, Z. (2004) The Concept of Placebo, Science and Engineering Ethics 10: 57-64.
6. Singer, E.A. (2004) The Necessity and the Value of Placebo, Science and Engineering Ethics 10: 51-56.
7. Joerden, J. (2004) Placebo and Criminal Law, Science and Engineering Ethics 10: 65-72.
8. Porzsolt F., Schlotz-Gorton N., Biller-Andorno N., Thim A., Meissner K., Roeckl-Wiedmann I., Herzberger B., Ziegler R., Gaus W., Pöppel E. (2004) Applying Evidence to Support Ethical Decisions: Is the Placebo Really Powerless? Science and Engineering Ethics 10: 119-132.
9. Barsky, A.J., Saintfort, R., Rogers, M.P., Bonis, J.F. (2002) Nonspecific Medication Side Effects and the Nocebo Phenomenon, JAMA 287: 622-627; excerpts from this paper, Science and Engineering Ethics 10: 133-134.
10. Barsky, A.J., Saintfort, R., Rogers, M.P., Bonis, J.F. (2002) Nonspecific Medication Side Effects and the Nocebo Phenomenon, JAMA 287: 622-627; excerpts from this paper, Science and Engineering Ethics 10: 133-134.
11. Zaborowski P. and Górski A. (2004) Informed Consent and the use of Placebo in Poland: Ethical and Legal Aspects, Science and Engineering Ethics 10: 167-178.
12. Wasilewski B. (2004) Homeopathic remedies as placebo alternatives - an example of treatment of menopause-related vegetative and emotional disturbances, Science and Engineering Ethics 10: 179-188.
13. Sugarman J. (2004) Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials, Science and Engineering Ethics 10: 29-35.
14. Miller, F.G. (2003) Sham Surgery: An Ethical Analysis, American Journal of Bioethics 3:4 (Fall), pp. 41-48; reprinted in Science and Engineering Ethics (2004) 10: 157-166.
15. Miller, F.G. (2003) Sham Surgery: An Ethical Analysis, American Journal of Bioethics 3:4 (Fall), pp. 41-48; reprinted in Science and Engineering Ethics (2004) 10: 157-166.
16. Vrhovac B. (2004) Placebo and the Helsinki Declaration - What to Do? Science and Engineering Ethics 10: 81-93.
17. Weihrauch T.R. (2004) Placebo treatment is effective differently in different diseases - but is it also harmless? Science and Engineering Ethics 10: 151-155.
18. de la Fuente-Fernández R. and Stoessl A.J. (2004) Biochemical Bases of the Placebo Effect, Science and Engineering Ethics 10: 143-150.